Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,547 | -1,370 | -8,153 | -5,965 | -4,356 |
| Depreciation Amortization | 378 | 189 | 685 | 514 | 343 |
| Accounts payable and accrued liabilities | -1,758 | -1,857 | 42 | -810 | 230 |
| Other Working Capital | -407 | -888 | 2,183 | 976 | 458 |
| Other Operating Activity | 1,777 | 1,860 | 39 | 890 | -150 |
| Operating Cash Flow | $-3,557 | $-2,066 | $-5,205 | $-4,395 | $-3,475 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,850 | 3,800 | 4,476 | 3,906 | 2,906 |
| Common Stock Issued | 5 | 5 | 674 | 615 | 594 |
| Financing Cash Flow | $4,855 | $3,805 | $5,150 | $4,521 | $3,500 |
| Exchange Rate Effect | -25 | -22 | N/A | N/A | N/A |
| Beginning Cash Position | 51 | 51 | 106 | 106 | 106 |
| End Cash Position | 1,324 | 1,768 | 51 | 232 | 131 |
| Net Cash Flow | $1,273 | $1,717 | $-55 | $126 | $25 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,557 | -2,066 | -5,205 | -4,395 | -3,475 |
| Free Cash Flow | -3,557 | -2,066 | -5,205 | -4,395 | -3,475 |